4:01pm ET
Investing
The 4 Stocks That Propped Up the Dow
thinkstockMay 19, 2014: Markets opened lower on Monday but look to close the day on the upside, even if just barely. There was no economic news of note today, no major earnings…
PFE Coverage Page 76
3:11pm ET
Telecom & Wireless
Pfizer Rises, AT&T Sinks to Lead the Dow’s Action
ThinkstockBig news from two of the market’s biggest names is making waves across Wall Street today as stocks advance through a quiet start to the week. The Dow Jones Industrial Average (DJINDICES: ^DJI) has…
10:53am ET
Special Report
The Best-Selling Products of All Time
ThinkstockCreating the most popular product of the year will make consumers and investors happy. But making an all-time bestseller can transform an industry and define a business for decades. Many of the…
4:01pm ET
Investing
The 4 Stocks That Tanked the Market
thinkstockMay 6, 2014: Markets opened lower on Monday and sank slowly and surely for the rest of the day. The dollar weakened against the yen overnight removing some enthusiasm for risk in…
11:05am ET
Health and Healthcare
Cross-Border Premium Implications in Merck-Bayer Transaction
Merck has had its consumer products business on the market since the beginning of this year, and Tuesday it announced that it had sold the business to Germany-based Bayer for $14.2 billion.
4:01pm ET
Investing
The 4 Stocks That Moved the Markets
thinkstockMay 5, 2014: Markets opened lower on Monday but gamely pushed to the upside in midafternoon. General concern over the situation in Ukraine and a weaker outlook on global growth prospects kept…
8:00am ET
Health and Healthcare
Pfizer Earnings Confirm Reasons for AstraZeneca Offer
Drug giant Pfizer reported better-than-expected first-quarter 2014 earnings before markets opened Monday morning, but revenues fell short. Shares traded lower in the premarket.
10:32am ET
Investing
The Top Eight Earnings for the Week Ahead
Jon OggEarnings season is far from over, but roughly three quarters of the stocks in the Standard & Poor’s 500 Index stocks have now reported their earnings for the first calendar quarter of…
8:55am ET
Health and Healthcare
AstraZeneca Declares Pfizer Bid ‘Inadequate’
British drug maker AstraZeneca once again rejected a takeover bid from U.S. pharmaceutical giant Pfizer, this one worth $106 billion (about £50 a share) in cash and stock.
4:01pm ET
Investing
The 4 Stocks That Led Markets Higher
thinkstockApril 28, 2014: Markets opened higher on Monday with little economic data to drive the market either up or down. Consequently shares fell then rose and look to be headed for small…
8:30am ET
Health and Healthcare
Biotech: The Poster Child for Market Volatility in 2014
The NYSE Arca Biotechnology Index fell nearly 9% between a peak on Jan. 22 and a low on Feb. 5. It jumped 23% over the next three weeks, and then gave it…
8:50am ET
Health and Healthcare
UBS Top Stocks to Buy Working for Cancer Cures
In a new research report, the Healthcare team at UBS took an in-depth look at the top companies that are making major advances in cancer therapeutics. Here is the UBS list of…
4:40pm ET
Investing
The 4 Stocks That Boosted Markets
thinkstockApril 21 2014: Markets opened higher on Monday but there wasn’t a lot of action as the only data out today was leading indicators, and they came in right on estimates. At…
1:25pm ET
Health and Healthcare
What a Combined Pfizer and AstraZeneca Would Look Like, and Face
ThinkstockIt is not that common that you hear about mergers in the $50 billion range. But what about when you hear of mergers in the $80 billion or $100 billion range? AstraZeneca…
10:40am ET
Health and Healthcare
Why Lpath Could Rise 300%
Canaccord Genuity is one of the few firms that are willing to cover small-cap biotech and emerging pharma stocks. Sometimes the price target upside is off the charts as well. In case…
Jon C. Ogg